Cancer Research Annual Meeting 2010  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 3708-3716, September 1, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Furuya, K. N.
Right arrow Articles by Schuetz, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Furuya, K. N.
Right arrow Articles by Schuetz, J. D.

Identification of a New P-glycoprotein-like ATP-binding Cassette Transporter Gene That Is Overexpressed during Hepatocarcinogenesis1

Katryn N. Furuya2, Grace Bradley, Daxi Sun, Erin G. Schuetz and John D. Schuetz3

Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee 38105 [K. N. F., D. S., E. G. S., J. D. S.]; Department of Pediatrics, University of Tennessee-Memphis, Memphis, Tennessee 38101 [K. N. F.]; and Department of Medical Biophysics, The Ontario Cancer Institute, University of Toronto, Toronto, Ontario, M4X 1K9 Canada [G. B.]

The liver is remarkably insensitive to a variety of cytotoxins and expresses a number of known drug resistance genes. To isolate new P-glycoprotein (Pgp)-related genes, we screened a normal rat liver cDNA library at low stringency with a MDRI cDNA fragment containing the P-loop and ATP binding site. We isolated a novel cDNA closely related to the Pgps that is dramatically increased in hepatic neoplasia and refer to it as P-glycoprotein-related protein (PRP). The predicted protein shows PRP to be a member of the ATP-Binding Cassette (ABC) family of proteins, and a multisequence comparison of the nucleotide binding domain and the ABC family signature sequences reveals that PRP sequences are highly conserved with the greatest similarity to the yeast heavy metal transporter encoded by htm1. However, the hydropathy plot analysis suggests that PRP does not have any prominent membrane-spanning domains and thus is not typical of ABC transporters. The PRP transcript is detected in many normal tissues. In the H35 hepatoma cell line, PRP was overexpressed compared to normal liver. Southern blot analysis of DNA from the H35 rat hepatoma cells reveals that the PRP gene was amplified compared to normal liver. The orotic acid model of hepatocarcinogenesis was used to determine if during stepwise progression to liver cancer, PRP changed with hepatocarcinogenesis. At the hyperplastic nodule stage, PRP expression was increased over its expression in normal surrounding liver. More dramatic increases in PRP expression were found in frank hepatic carcinomas. Cumulatively, these studies are the first to link a novel ABC family member to the hepatic neoplastic process, a role that may be recapitulated in other cells, considering the ubiquitous expression of PRP.

1 This work was supported in part by National Institute of Environmental Health Sciences Grants ES05851 (to J. D. S.) and ES04628 (to E. G. S.), by NIH grant CA63230 and NIH/NCI Cancer Center Support (CORE) Grant CA21765, by the Duncan L. Gordon Fellowship from The Hospital for Sick Children Foundation, Toronto, Ontario, Canada (to K. N. F.), by a Center of Excellence Grant from the State of Tennessee (to K. N. F.), and by funds from the American Lebanese Syrian Associated Charities.

2 Present address: Division of Gastroenterology and Nutrition, The Hospital for Sick Children, The University of Toronto, 555 University Avenue, Toronto, Ontario, M5G 1X8 Canada.

3 To whom requests for reprints should be addressed, at Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, 332 North Lauderdale Avenue, Memphis, TN 38105. Phone: (901) 495-2174; Fax: (901) 525-6869; E-mail: john.schuetz@stjude.org.

Received 10/ 2/96. Accepted 7/ 1/97.




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
Y. Abdul Jalil, V. Ritz, A. Jakimenko, C. Schmitz-Salue, H. Siebert, D. Awuah, A. Kotthaus, T. Kietzmann, C. Ziemann, and K. I. Hirsch-Ernst
Vesicular localization of the rat ATP-binding cassette half-transporter rAbcb6
Am J Physiol Cell Physiol, February 1, 2008; 294(2): C579 - C590.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Shibutani, N. Takahashi, T. Kobayashi, C. Uneyama, N. Masutomi, A. Nishikawa, and M. Hirose
Molecular profiling of genes up-regulated during promotion by phenobarbital treatment in a medium-term rat liver bioassay
Carcinogenesis, June 1, 2002; 23(6): 1047 - 1055.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. J. Lim, M. J. Parr, D. Masin, N. L. McIntosh, T. D. Madden, G. Zhang, S. Johnstone, and M. B. Bally
Kupffer Cells Do Not Play a Role in Governing the Efficacy of Liposomal Mitoxantrone Used to Treat a Tumor Model Designed to Assess Drug Delivery to Liver
Clin. Cancer Res., November 1, 2000; 6(11): 4449 - 4460.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.